Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,803,510
+$5,002,038 QoQ
Shares Held
18,788
+267.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#693
of 3,140 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brevan Howard Capital Management LP holds $180,596,811 across 9 Drug Manufacturers - General names. AMGN ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
77,094 | $92,468,863 | |
| 2 | ABBV |
AbbVie Inc.
|
115,264 | $29,005,032 | |
| 3 | JNJ |
Johnson & Johnson
|
62,412 | $15,850,774 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
123,329 | $15,581,385 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
163,962 | $9,447,490 | |
| 6 | AMGN |
Amgen Inc
This page
|
18,788 | $6,803,510 | |
| 7 | MRK |
Merck & Co., Inc.
|
50,031 | $6,428,983 | |
| 8 | AZN |
Astrazeneca PLC
|
20,152 | $3,821,222 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,803,510 | 18,788 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,801,472 | 5,120 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $920,395 | 2,812 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,338,474 | 4,743 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,224,298 | 18,711 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,871,545 | 22,056 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,207,965 | 3,749 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $265,554 | 922 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||